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Of all the spontaneous fistulas that occur between the extrahepatic biliary system and the
intestine, a choledochoduodenal fistula is rarely seen. When it does occur, it is most often
secondary to a perforated duodenal ulcer, choledocholithiasis, or cholelithiasis. It may also
be seen following complications related to iatrogenic injury or tuberculosis. Generally,
choledochoduodenal fistulas are asymptomatic, but may present with vague abdominal
pain, fever, and other symptoms related to cholangitis. As a result, they can be difficult to
diagnose clinically before imaging is obtained. We present a case of a 74 year old,
asymptomatic, female with a past medical history significant for Crohn's disease who was
found to have a choledochoduodenal fistula demonstrated on MRCP, possibly secondary to
her underlying inflammatory bowel disease.
© 2016 the Authors. Published by Elsevier Inc. under copyright license from the University
of Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
A bilioenteric fistula is an abnormal connection between the
biliary tract and the intestines. Of all the spontaneous fistulas
that develop between the extrahepatic biliary ducts and
intestines, cholecystoduodenal fistulas are the most common
[1,2]. Although rare, an abnormal connection between
the common bile duct (CBD) and duodenum can also
occur forming a choledochoduodenal fistula (CDF). A CDF
most commonly arises in the setting of choledocholithiasis,
cholelithiasis, or a perforated duodenal ulcer [1e5]. CDFs have
also been reported as a complication secondary to recurrent
biliary infections, adjacent neoplasm, tuberculosis, radiation,
and iatrogenic injury [6e8]. To the best of our knowledge,
there has been only one reported case of a CDF occurring in
the setting of Crohn’s disease (CD) to date [9]. Patients with CD
have an increased risk of developing gastrointestinal fistulas
due to chronic inflammation of the gastrointestinal tract.lared that no competing
pping).
Elsevier Inc. under copy
se (http://creativecommoCDFs generally do not present with specific clinical symp-
toms. In fact, they are often found incidentally on imaging,
including endoscopic retrograde cholangiopancreatography
(ERCP) and magnetic resonance cholangiopancreatography
(MRCP) [4e6,10]. If symptoms are present, they are frequently
related to the primary cause of the CDF.
We present a case of a 74-year-old asymptomatic woman
with history of CD who presented for 1-year follow-up for
surveillance magnetic resonance enterography (MRE) and
MRCP and was found to have a CDF on imaging.Case report
Our patient is a 74-year-old woman with a long history of
inflammatory bowel disease (IBD) characterized by fistulizing
CD. She was first diagnosed with CD by a screening colonos-
copy 5 years prior. She has tried multiple drug regimens forinterests exist.
right license from the University of Washington. This is an open
ns.org/licenses/by-nc-nd/4.0/).
Fig. 2 e T1-weighted postcontrast (coronal) sequence
demonstrating hyperemia (arrow) in the same segment of
distal ileum signifying acute on chronic disease.
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chronic inflammation with acute exacerbations. Two years
ago, her disease was further complicated by a small bowel
perforation with microabscesses anterior to the terminal
ileum, which required hospitalization. Surveillance MRE
demonstrated persistent acute on chronic inflammation in
the small bowelwith an enteroenteric fistula in the right lower
quadrant [Figure 1]. One year ago, the patient was started on
infliximab (Remicade; Janssen Biotech, Inc, Horsham, PA) and
has since remained asymptomatic. She returned 1 year later
for repeat MRE, which showed resolution of the enteroenteric
fistula and improved, but persistent, acute on chronic
inflammation in the terminal ileum [Figure 2].
In addition, a MRCP was performed to evaluate for under-
lying causes of chronically elevated alkaline phosphatase. For
the past 2 years, our patient’s alkaline phosphatase level
ranged from 115 to 203 U/L, most recently measuring 125 U/L.
Furthermore, her total bilirubin, aspartate aminotransferase,
alanine aminotransferase, and gamma-glutamyltransferase
levels have remained within normal limits. On in-depth
review of available prior imaging of our patient’s medical
chart, she has never demonstrated an obstructive biliary
process that could explain her isolated elevated alkaline
phosphatase. On MRCP, a large fistulous connection was seen
between the proximal CBD and proximal second portion of the
duodenum with associated internal debris and dilation of the
remainder of the CBD [Figure 3]. Pneumobilia was noted in the
CBD and intrahepatic biliary radials, predominantly in the left
hepatic lobe [Figure 4]. These findings, best visualized on the
coronal T2-weighted sequences, are consistent with a CDF
[Figure 5].Fig. 1 e Coronal true fast imaging with steady-state free
precession (TRUFI) sequence demonstrating a long
segment of distal ileum with wall stratification and
thickening (arrows).On further review of our patient’s medical chart, she was
diagnosed with a CDF on a remote ERCP for investigation
of incidental pneumobilia. Unfortunately, no images of her
ERCP are available for review. Surgical treatment for her CDF
was not indicated at that time, and she was subsequently
followed clinically by her gastroenterologist. Before this
incidental finding, the patient had no significant history,
symptoms, or imaging findings suggestive of cholelithiasis,
choledocholithiasis, or duodenal ulcerative disease.Fig. 3 eMRCPdetailing thebiliary tree (righthepatic duct [R],
left hepatic duct [L], and common bile duct [CBD]) with
fistulous connection (F) between theCBDandduodenum(D).
Fig. 4 e T1-weighted in-phase (axial) sequence showing
pneumobilia (arrows).
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A CDF is an abnormal connection between the CBD and
duodenum. It is a rare condition, as approximately only 3.5%
of all bilioenteric fistulas that occur are CDFs. CDFs likely form
due to the close proximity of the first portion of the duodenum
and the CBD as it courses through the hepatoduodenal liga-
ment [1]. When CDFs occur, they do so typically in the setting
of choledocholithiasis or a perforated duodenal ulcer. An
abnormal, often short, fistulous tract develops secondary to
inflammation from a gallstone eroding into the duodenum
from within the CBD or a perforated ulcer [1e5].
Regardless of the etiology, CDFs are often asymptomatic
[1e6,10]. Symptoms of ascending cholangitis are infrequently
observed and previously reported cases have demonstrated
evidence of a long-standing CDF without a history suggestiveFig. 5 e T2 sampling perfection with application optimized
contrasts using different flip angle evolution (SPACE)
maximal intensity projection (MIP) coronal image detailing
the biliary tree with fistulous connection (F) between the
common bile duct (CBD) and the duodenum (D).of cholangitis [1,10,11]. Our patient did not have a medical
history of, imaging findings suggestive of, or typical clinical
symptoms indicative of cholelithiasis, choledocholithiasis, or
a duodenal ulcer. Nonetheless, these processes are difficult to
definitively exclude as potential etiologies. As such, we
recognize that we cannot disregard the possibility that our
patient’s CDF may have been caused by remote perforated
duodenal ulcer or choledocholithiasis.
Consequently, given our patient’s history, the possibility
remains that her CDF could be explained by another process.
She has no history of tuberculosis, radiation, or prior
procedure to have caused iatrogenic injury of the CBD. She
does, however, have an extensive history of CD and has had
multiple complications secondary to her gastrointestinal
inflammation. In CD, inflammation can occur along any part
of the gastrointestinal tract, including the duodenum, which
can lead to the formation of a CDF. A population-based study
from the community of Olmstead, Minnesota looking at the
natural history of CD found the cumulative risk of developing
any type of fistula after 1, 5, 10, and 20 years after the diagnosis
of CD was found to be 21%, 26%, 33%, and 50%, respectively
[12]. The lifetime risk of developing a fistula in a patient with
CD is between 20%-40% [13]. Our patient has a greater risk of
developing a fistulous gastrointestinal tract compared with
the general population given her chronic inflammatory state.
Identifying a CDF on imaging is often necessary in its
diagnosis as it is frequently clinically asymptomatic [4e6,10].
MRCP is less invasive than ERCP and has become an accepted
technique in thoroughly examining the intrahepatic and
extrahepatic biliary system [14]. Imaging findings are the best
seen on fluid sensitive, heavily T2-weighted images obtained
fast spin echo or single-shot fast spin echo. For our patient,
coronal T2-weighted images show a wide, short connection
between the CBD and the proximal duodenum. In addition,
pneumobilia was best identified as a hypointense signal on
T1-weighted in-phase images, thus further validating the
presence of a CDF.
The treatment of a CDF depends on its etiology, severity, and
the overall clinical condition of the patient, especially as a
standard management of this condition has not been estab-
lished [6]. If the CDF occurs as a complication of a perforated
duodenal ulcer, the patient would need to be appropriately
treatedmedically or surgically, depending on the severity of the
ulcer. A CDF occurring as a complication of cholelithiasis or
choledocholithiasis often warrants appropriate endoscopic or
surgical treatment to remove the offending stones. For large
CDFs causing severe clinical symptoms, surgery may be rec-
ommended to best repair the biliary tract. If a patient is asymp-
tomatic, however, somestudiessuggest only regular clinical and
laboratory follow-up are neededwhile the fistula heals [6].
Before her current presentation, our patient’s CDF was
identified on a remote ERCP after an incidental finding of
pneumobilia on abdominal CT (prior ERCP images were not
available in patient’s medical chart). As she had no signs or
symptoms to suggest cholangitis at that time, she received
conservative clinical surveillance and management. She did
not receive endoscopic or surgical therapy, thus, the CDF seen
on the current MRCP is likely the same fistula identified in the
prior ERCP. Although our patient’s IBD has appeared well
controlled on current therapy over the past 2 years, she has a
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abdominal abscess formation indicating persistent or recur-
rent acute on chronic inflammation throughout her gastro-
intestinal tract, which is the likely reason for her CDF.
Although CDFs rarely occur, it is important to understand
the etiology and imaging characteristics behind these fistulas.
It is important not only to advance our knowledge and
understanding of this disease process, but to also be able to
better manage our patients who present with this condition.
We are reporting this case of a CDF to highlight its occurrence
in the setting of fistulizing CD which has been infrequently
documented in the past.r e f e r e n c e s
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